Carregant...

Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure

The worldwide prevalence of heart failure is increasing in part because of an aging population. In the developed world, heart failure affects 1%–2% of the general population, accounting for 5% of adult hospital admissions. There is now convincing evidence supporting the beneficial effects of cardiac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ellery, S, Williams, L, Frenneaux, M
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2563719/
https://ncbi.nlm.nih.gov/pubmed/16397075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/pgmj.2005.034199
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!